AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
SGLT to Inhibitor Trials in Nephrology
The body of evidence that we have for SGLT to inhibitors is greater and stronger than we've ever had in nephrology. We're expanding what these drugs can do and where these have been shown to be effective. And there are still questions and SLT2 inhibitors even after Epic kidney, or I'm excited to see those,. like with things that we have not been answered, transplant patients. The broad strokes are the kind of the same as we've seen before, these drugs just work; we're just pushing out the boundaries of where we show that they work.